Johnson & Johnson's Prostate Cancer Drug JNJ-6143 Shrinks Tumours In Early Trial
Digipreneur Ashish
Sunday, October 25, 2026
0
In the early-stage trial, 77% of 31 evaluable patients receiving the 50-milligram dose experienced a PSA decline of at least 50%, while 48% ...
Read more »
Posts
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
Email Subscription
Socialize